about
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.Quantitative Assessment of Heterogeneity in Bladder Tumor MRI Diffusivity: Can Response be Predicted Prior to Neoadjuvant Chemotherapy?Bladder cancer: Conditional survival after radical cystectomy.Principal component analysis based pre-cystectomy model to predict pathological stage in patients with clinical organ-confined bladder cancer.[Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer].Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neoadjuvant chemotherapy for invasive bladder cancer.
@en
Neoadjuvant chemotherapy for invasive bladder cancer.
@nl
type
label
Neoadjuvant chemotherapy for invasive bladder cancer.
@en
Neoadjuvant chemotherapy for invasive bladder cancer.
@nl
prefLabel
Neoadjuvant chemotherapy for invasive bladder cancer.
@en
Neoadjuvant chemotherapy for invasive bladder cancer.
@nl
P2860
P1476
Neoadjuvant chemotherapy for invasive bladder cancer.
@en
P2093
Cora N Sternberg
Guru Sonpavde
P2860
P2888
P304
P356
10.1007/S11934-012-0236-2
P577
2012-04-01T00:00:00Z